Texans wide receiver John Metchie III, a second-round rookie, will miss the 2022 season, but it has nothing to do with the torn ACL he suffered in this year’s SEC title game. Unfortunately, the Alabama product has been diagnosed with leukemia.
Metchie released a statement indicating that the diagnosis is Acute Promyelocytic Leukemia, which he says is the most curable form of the disease. He added that he is in good spirits and expects to make a full recovery, but that he will not be playing football this year.
Although the Texans knew that the ACL tear would quite possibly force Metchie to miss time in his rookie campaign, it was expected that he would be able to suit up at some point this season. Indeed, the club was comfortable enough with his medicals to trade away pick nos. 68, 108, and 124 to move up the board and nab Metchie with the No. 44 overall selection.
In 13 games in his final collegiate season, Metchie posted 96 receptions for 1,142 yards and eight scores. Whenever he was medically cleared, he was expected to serve as Houston’s primary slot receiver and as a high-upside weapon for second-year QB Davis Mills. At present, the Texans’ WR depth chart is topped by Brandin Cooks and Nico Collins, but the options behind those two are fairly uninspiring.
Now, Metchie and Houston can only hope that 2023 will bring better fortune. We here at PFR wish Metchie the best in his recovery.